Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Kapa65 / Pixabay

Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C

According to a story from Charcot-Marie-Tooth News, early preliminary testing of a possible gene therapy treatment for a certain type of Charcot-Marie-Tooth disease showed potential in a mouse model. This…

Continue Reading Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing
Fotorech / Pixabay

Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing

According to a story from Pulmonary Hypertension News, the drug developer United Therapeutics recently issued a statement in which the company announced that it was ceasing the development of esuberaprost…

Continue Reading Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing

ISMRD International Conference for Glycoprotein Storage Diseases Coming This July

Upcoming Conference The International Society for Mannosidosis & Related Diseases (ISMRD) serves as an international patient advocate for those living with glycoprotein storage diseases. These include alpha-mannosidosis, fucosidosis, mucolipidosis type…

Continue Reading ISMRD International Conference for Glycoprotein Storage Diseases Coming This July
Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis
stux / Pixabay

Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

According to a story from AJC, three year old Reid Peteet is one of over 550 kids that have been diagnosed with acute flaccid myelitis since 2014. 2018 saw a…

Continue Reading Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

Experimental Drug for HPV-Linked Recurrent Respiratory Papillomatosis Shows Early Promise

According to a press release from Inovio Pharmaceuticals, the American biotech company's experimental recurrent respiratory papillomatosis (RRP) drug INO-3106 showed promising results at the end of a pilot clinical study…

Continue Reading Experimental Drug for HPV-Linked Recurrent Respiratory Papillomatosis Shows Early Promise
European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation
Capri23auto / Pixabay

European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation

According to a press release from American biotechnology company Soligenix, the European Medicines Agency's (EMA) Pediatric Committee recently agreed to the Company’s Pediatric Investigation Plan (PIP) for experimental oral mucositis…

Continue Reading European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation

New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants

  An article in BioSpace reports new information published online by the NEJM concerning Hirschsprung disease. The disease involves the absence of nerves in parts of the intestines prior to birth. Researchers…

Continue Reading New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants

Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis

Nigam Shah and Purvesh Khatri, professors at Stanford University, along with graduate student Madeleine Scott have just announced results from a research study which could be pivotal for those living…

Continue Reading Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis